253 related articles for article (PubMed ID: 37100824)
1. Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection.
Kilinc F; Setzer M; Behmanesh B; Jussen D; Gessler F; Keil F; Kempf VAJ; Kessel J; Czabanka M; Prinz V
Sci Rep; 2023 Apr; 13(1):6863. PubMed ID: 37100824
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection.
Kilinc F; Setzer M; Behmanesh B; Jussen D; Gessler F; Bayerl S; Kempf VAJ; Kessel J; Czabanka M; Prinz V
Front Med (Lausanne); 2023; 10():1202969. PubMed ID: 37942421
[TBL] [Abstract][Full Text] [Related]
3. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
5. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
Suleyman G; Kenney R; Zervos MJ; Weinmann A
J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections.
Seaton RA; Sharp E; Bezlyak V; Weir CJ
Int J Antimicrob Agents; 2011 Sep; 38(3):243-8. PubMed ID: 21741221
[TBL] [Abstract][Full Text] [Related]
8. Outpatient parenteral antimicrobial therapy for orthopedic infections - a successful public healthcare experience in Brazil.
Oliveira PR; Felix Cda S; Carvalho VC; Giovani AM; Reis RS; Beraldo M; Albuquerque EP; Ferreira WC; Silva Jdos S; Lima AL
Braz J Infect Dis; 2016; 20(3):272-5. PubMed ID: 27102779
[TBL] [Abstract][Full Text] [Related]
9. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
Dimitrova M; Gilchrist M; Seaton RA
BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
[TBL] [Abstract][Full Text] [Related]
10. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
Bhavan KP; Brown LS; Haley RW
PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
[TBL] [Abstract][Full Text] [Related]
11. [The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
Hase R; Hosokawa N; Uno S; Mikawa T; Uwamino Y; Muranaka K
Kansenshogaku Zasshi; 2014 May; 88(3):269-74. PubMed ID: 24974449
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
[TBL] [Abstract][Full Text] [Related]
13. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients.
Beieler AM; Dellit TH; Chan JD; Dhanireddy S; Enzian LK; Stone TJ; Dwyer-O'Connor E; Lynch JB
J Hosp Med; 2016 Aug; 11(8):531-5. PubMed ID: 27120700
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Huang V; Ruhe JJ; Lerner P; Fedorenko M
BMC Pharmacol Toxicol; 2018 Aug; 19(1):50. PubMed ID: 30081959
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
Means L; Bleasdale S; Sikka M; Gross AE
Pharmacotherapy; 2016 Aug; 36(8):934-9. PubMed ID: 27393717
[TBL] [Abstract][Full Text] [Related]
18. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
Palms DL; Jacob JT
Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
[TBL] [Abstract][Full Text] [Related]
19. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
[TBL] [Abstract][Full Text] [Related]
20. Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation.
Allen N; Adam M; O'Regan G; Seery A; McNally C; McConkey S; Brown A; de Barra E
BMC Infect Dis; 2021 Jul; 21(1):670. PubMed ID: 34243725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
